With a global market that is exceeding 1 trillion dollars and projections over the next five years of double digit growth, it is an exciting time for life sciences companies. Emerging markets provide attractive growth opportunities for life sciences companies. But life sciences companies should proceed with caution. While emerging markets may represent incredible growth opportunities, they are still developing, and many have reputations for seemingly pervasive corruption in their business practices and processes. It is critical for companies to know the risks to effectively capitalize on opportunities for growth.